118 related articles for article (PubMed ID: 8150999)
1. Cytochromes in psychopharmacology.
von Moltke LL; Greenblatt DJ; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1994 Feb; 14(1):1-4. PubMed ID: 8150999
[No Abstract] [Full Text] [Related]
2. A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.
Bork JA; Rogers T; Wedlund PJ; de Leon J
J Clin Psychiatry; 1999 Jul; 60(7):469-76. PubMed ID: 10453802
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant drug interactions with antiretroviral agents.
Burger DM; Hoetelmans RM; Koopmans PP; Meenhorst PL; Mulder JW; Hekster YA; Beijnen JH
Antivir Ther; 1997 Jul; 2(3):149-65. PubMed ID: 11322270
[TBL] [Abstract][Full Text] [Related]
4. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
[TBL] [Abstract][Full Text] [Related]
5. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.
Paine MF; Khalighi M; Fisher JM; Shen DD; Kunze KL; Marsh CL; Perkins JD; Thummel KE
J Pharmacol Exp Ther; 1997 Dec; 283(3):1552-62. PubMed ID: 9400033
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
7. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of cytochrome P450 3A in psychopharmacology.
Ketter TA; Flockhart DA; Post RM; Denicoff K; Pazzaglia PJ; Marangell LB; George MS; Callahan AM
J Clin Psychopharmacol; 1995 Dec; 15(6):387-98. PubMed ID: 8748427
[TBL] [Abstract][Full Text] [Related]
9. Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer.
Romkes M; Chern HD; Lesnick TG; Becich MJ; Persad R; Smith P; Branch RA
Carcinogenesis; 1996 May; 17(5):1057-62. PubMed ID: 8640913
[TBL] [Abstract][Full Text] [Related]
10. Grapefruits and drugs: when is statistically significant clinically significant?
Abernethy DR
J Clin Invest; 1997 May; 99(10):2297-8. PubMed ID: 9153265
[No Abstract] [Full Text] [Related]
11. Risperidone-carbamazepine interactions: is cytochrome P450 3A involved?
Lane HY; Chang WH
J Clin Psychiatry; 1998 Aug; 59(8):430-1. PubMed ID: 9721825
[No Abstract] [Full Text] [Related]
12. Induction of CYP2D6 in pregnancy.
Wadelius M; Darj E; Frenne G; Rane A
Clin Pharmacol Ther; 1997 Oct; 62(4):400-7. PubMed ID: 9357391
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanism of the expression and modulation of CYP3A gene].
Wang JS; Zhou HH
Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):173-6. PubMed ID: 12501692
[No Abstract] [Full Text] [Related]
14. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of interleukin-10 on human cytochrome P450 activity.
Gorski JC; Hall SD; Becker P; Affrime MB; Cutler DL; Haehner-Daniels B
Clin Pharmacol Ther; 2000 Jan; 67(1):32-43. PubMed ID: 10668851
[TBL] [Abstract][Full Text] [Related]
16. CYP3A genetics in drug metabolism.
Eichelbaum M; Burk O
Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
[No Abstract] [Full Text] [Related]
17. Oral erythromycin and the risk of sudden death.
Amory JK; Amory DW
N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669119
[No Abstract] [Full Text] [Related]
18. CYP3A and drug interactions.
Med Lett Drugs Ther; 2005 Jul; 47(1212):54-5. PubMed ID: 15988399
[No Abstract] [Full Text] [Related]
19. Cisapride (Prepulsid): interactions with grapefruit and drugs.
Morawiecka I
CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
[No Abstract] [Full Text] [Related]
20. Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes.
Postlind H; DanielsonA ; Lindgren A; Andersson SH
Drug Metab Dispos; 1998 Apr; 26(4):289-93. PubMed ID: 9531513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
